Immunicum’s vaccine INTUVAC is mentioned in Thomson Reuters

  • 17:50

Immunicum vaccine INTUVAC is mentioned in Thomson Reuters’ “A Pharma Matters Report: THE ONES TO WATCH” as one of the most promising drugs to change clinical phase in Q1 2012. Read the report here.